Drug · DIN 02334992
ENDOMETRIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 10, 2026; first marketed November 30, 2009.
- Drug Identification Number (DIN)
- 02334992
- Company (DIN owner)
- Ferring Inc.North York, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Vaginal Tablet (Effervescent)
- Route
- Vaginal
- Therapeutic class (ATC)
- Progesterone G03DA04
- Class
- Human
- Record last updated
- September 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PROGESTERONE | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 2, 2009: NOC 10630New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “endometrin”. A notice may cover another product or only some lots: read it to see what it covers.
- Endometrin effervescent vaginal tablets; Burkholderia contaminationJune 2, 2023 · Drugs · Contamination · Type II
- ENDOMETRIN (100 mg Progesterone Effervescent Vaginal Tablets) - Voluntary Recall of Two Lots Due to a Possible Lack of Therapeutic Efficacy - For Health ProfessionalsNovember 26, 2013 · Drugs · Product safety
- In vitro fertilization product (Endometrin) recalled due to possible problems with effectivenessNovember 22, 2013 · Drugs · Product safety